Eribulin Mesylate Injection
Product Images NDC 68462-770

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 68462-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Image1)

FDA Label Image

Image2 (Image2)

Image2 (Image2)
This description is not available.*
FDA Label Image

Image3 (Image3)

FDA Label Image

Image4 (Image4)

Image4 (Image4)
Glenmark is a pharmaceutical company known for manufacturing and providing a variety of healthcare products.*
FDA Label Image

Image5 (Image5)

FDA Label Image

Image6 (Image6)

Image6 (Image6)
This is a description of a sterile solution of Eribulin Mesylate in a single-dose vial at a concentration of 1 mg/2 mL. It is important to store the solution at 25°C (77°F) and avoid freezing or refrigeration. The product is a cytotoxic agent for intravenous use and any unused portion of the vial should be discarded. This medication is distributed by Glenmark Pharmaceuticals Inc., USA, and is a product of China. The text references additional prescribing information for dosage and use.*
FDA Label Image

Image7 (Image7)

Image7 (Image7)
This text is related to a medication called Eribulin Mesylate, which is a sterile solution for intravenous use. It is a cytotoxic agent and comes in single-dose vials containing 1 mg of eribulin mesylate in 2 ml of solution, with each ml containing 0.5 mg of eribulin. The solution also contains dehydrated alcohol and water for injection. The medication should be stored at room temperature (25°C) and protected from freezing or refrigeration. It is distributed by Glenmark Pharmaceuticals Inc., USA. Please refer to the accompanying prescribing information for dosage and usage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.